

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of oxidative stress-induced neuron death (GO:1903203) | 6.57358648 |
| 2 | positive regulation of cellular response to oxidative stress (GO:1900409) | 5.62814741 |
| 3 | positive regulation of response to oxidative stress (GO:1902884) | 5.62814741 |
| 4 | response to interleukin-15 (GO:0070672) | 5.40506181 |
| 5 | angiogenesis involved in wound healing (GO:0060055) | 5.35183064 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.29862605 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.16435735 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16435735 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.16268091 |
| 10 | aggressive behavior (GO:0002118) | 5.09235082 |
| 11 | myoblast migration (GO:0051451) | 5.04663076 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.86264234 |
| 13 | negative regulation of cell killing (GO:0031342) | 4.86264234 |
| 14 | positive regulation of hormone biosynthetic process (GO:0046886) | 4.78616732 |
| 15 | regulation of T cell tolerance induction (GO:0002664) | 4.66900616 |
| 16 | thrombin receptor signaling pathway (GO:0070493) | 4.65591827 |
| 17 | positive thymic T cell selection (GO:0045059) | 4.55232693 |
| 18 | negative thymic T cell selection (GO:0045060) | 4.55024126 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.41825947 |
| 20 | regulation of female receptivity (GO:0045924) | 4.40248433 |
| 21 | energy homeostasis (GO:0097009) | 4.39783031 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.35621403 |
| 23 | embryonic process involved in female pregnancy (GO:0060136) | 4.32794381 |
| 24 | monocyte differentiation (GO:0030224) | 4.31374614 |
| 25 | negative T cell selection (GO:0043383) | 4.28385139 |
| 26 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.17302290 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.05379822 |
| 28 | female mating behavior (GO:0060180) | 4.03537614 |
| 29 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.02469907 |
| 30 | positive regulation of tolerance induction (GO:0002645) | 4.01241346 |
| 31 | type B pancreatic cell development (GO:0003323) | 3.99104440 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98057631 |
| 33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.96134045 |
| 34 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.88085105 |
| 35 | thymic T cell selection (GO:0045061) | 3.86161662 |
| 36 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.83875353 |
| 37 | regulation of histone H3-K27 methylation (GO:0061085) | 3.78316760 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.76698423 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.76162805 |
| 40 | regulation of histone H3-K9 methylation (GO:0051570) | 3.73114320 |
| 41 | negative regulation of fatty acid transport (GO:2000192) | 3.70439290 |
| 42 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.69636913 |
| 43 | Peyers patch development (GO:0048541) | 3.69636913 |
| 44 | embryonic hemopoiesis (GO:0035162) | 3.67192696 |
| 45 | megakaryocyte development (GO:0035855) | 3.66027278 |
| 46 | regulation of erythrocyte differentiation (GO:0045646) | 3.65478609 |
| 47 | T cell costimulation (GO:0031295) | 3.65225428 |
| 48 | positive regulation of hormone metabolic process (GO:0032352) | 3.64701910 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.64018781 |
| 50 | regulation of tolerance induction (GO:0002643) | 3.62884827 |
| 51 | granulocyte differentiation (GO:0030851) | 3.61215067 |
| 52 | regulation of endothelial cell differentiation (GO:0045601) | 3.59956282 |
| 53 | lymphocyte costimulation (GO:0031294) | 3.57237001 |
| 54 | positive regulation of histone deacetylation (GO:0031065) | 3.53537259 |
| 55 | positive regulation of granulocyte differentiation (GO:0030854) | 3.53067525 |
| 56 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.51862687 |
| 57 | T cell selection (GO:0045058) | 3.51344781 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.49330989 |
| 59 | positive T cell selection (GO:0043368) | 3.45014642 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.43996624 |
| 61 | base-excision repair, AP site formation (GO:0006285) | 3.41800990 |
| 62 | grooming behavior (GO:0007625) | 3.41685217 |
| 63 | pyrimidine dimer repair (GO:0006290) | 3.41008795 |
| 64 | regulation of response to interferon-gamma (GO:0060330) | 3.38636533 |
| 65 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.35265449 |
| 66 | natural killer cell differentiation (GO:0001779) | 3.34959631 |
| 67 | phospholipid scrambling (GO:0017121) | 3.34376767 |
| 68 | negative regulation of B cell proliferation (GO:0030889) | 3.33556825 |
| 69 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.33530614 |
| 70 | cellular response to interleukin-15 (GO:0071350) | 3.31987812 |
| 71 | DNA deamination (GO:0045006) | 3.31154362 |
| 72 | regulation of B cell differentiation (GO:0045577) | 3.28927882 |
| 73 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.28596962 |
| 74 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.26599975 |
| 75 | hepatocyte apoptotic process (GO:0097284) | 3.26561323 |
| 76 | mRNA splice site selection (GO:0006376) | 3.25590039 |
| 77 | negative regulation of mRNA processing (GO:0050686) | 3.25360656 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23957358 |
| 79 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.23293351 |
| 80 | dendritic cell chemotaxis (GO:0002407) | 3.21925270 |
| 81 | B cell receptor signaling pathway (GO:0050853) | 3.21830860 |
| 82 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.21743235 |
| 83 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.21743235 |
| 84 | negative regulation of necroptotic process (GO:0060546) | 3.21377739 |
| 85 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.21301066 |
| 86 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.21301066 |
| 87 | NADH dehydrogenase complex assembly (GO:0010257) | 3.21301066 |
| 88 | maternal behavior (GO:0042711) | 3.20146123 |
| 89 | negative regulation of telomere maintenance (GO:0032205) | 3.18839245 |
| 90 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.18137448 |
| 91 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.17538381 |
| 92 | regulation of megakaryocyte differentiation (GO:0045652) | 3.16153831 |
| 93 | pseudouridine synthesis (GO:0001522) | 3.15505866 |
| 94 | negative regulation of anoikis (GO:2000811) | 3.15401553 |
| 95 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 3.14346847 |
| 96 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.13476379 |
| 97 | endothelial tube morphogenesis (GO:0061154) | 3.12716903 |
| 98 | morphogenesis of an endothelium (GO:0003159) | 3.12716903 |
| 99 | protein complex biogenesis (GO:0070271) | 3.12182972 |
| 100 | parental behavior (GO:0060746) | 3.10473006 |
| 101 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.10303537 |
| 102 | regulation of necroptotic process (GO:0060544) | 3.09841304 |
| 103 | positive regulation of erythrocyte differentiation (GO:0045648) | 3.08410347 |
| 104 | lamellipodium assembly (GO:0030032) | 3.08156819 |
| 105 | leukocyte aggregation (GO:0070486) | 3.05598607 |
| 106 | iron-sulfur cluster assembly (GO:0016226) | 3.04726521 |
| 107 | metallo-sulfur cluster assembly (GO:0031163) | 3.04726521 |
| 108 | regulation of steroid hormone biosynthetic process (GO:0090030) | 3.04533045 |
| 109 | ubiquinone biosynthetic process (GO:0006744) | 3.04352680 |
| 110 | definitive hemopoiesis (GO:0060216) | 3.04037655 |
| 111 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.03312368 |
| 112 | cellular hyperosmotic response (GO:0071474) | 3.01200900 |
| 113 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00347706 |
| 114 | positive regulation of lamellipodium organization (GO:1902745) | 3.00257031 |
| 115 | platelet dense granule organization (GO:0060155) | 2.98488677 |
| 116 | valine metabolic process (GO:0006573) | 2.97070824 |
| 117 | positive regulation of steroid hormone secretion (GO:2000833) | 2.96818366 |
| 118 | negative regulation of viral release from host cell (GO:1902187) | 2.96490752 |
| 119 | GMP metabolic process (GO:0046037) | 2.95002047 |
| 120 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.94739151 |
| 121 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.93629511 |
| 122 | negative regulation of mast cell activation (GO:0033004) | 2.93416796 |
| 123 | lamellipodium organization (GO:0097581) | 2.92472078 |
| 124 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.91814867 |
| 125 | glandular epithelial cell development (GO:0002068) | 2.90495561 |
| 126 | deoxyribonucleotide catabolic process (GO:0009264) | 2.89518968 |
| 127 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.89414008 |
| 128 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.88873757 |
| 129 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.88847643 |
| 130 | positive regulation of prostaglandin secretion (GO:0032308) | 2.88379433 |
| 131 | dendritic cell migration (GO:0036336) | 2.87310155 |
| 132 | endothelium development (GO:0003158) | 2.86847194 |
| 133 | trabecula morphogenesis (GO:0061383) | 2.86753784 |
| 134 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.86734471 |
| 135 | fucose catabolic process (GO:0019317) | 2.85911498 |
| 136 | L-fucose metabolic process (GO:0042354) | 2.85911498 |
| 137 | L-fucose catabolic process (GO:0042355) | 2.85911498 |
| 138 | growth hormone receptor signaling pathway (GO:0060396) | 2.85891185 |
| 139 | regulation of transmission of nerve impulse (GO:0051969) | 2.84624908 |
| 140 | negative regulation of RNA splicing (GO:0033119) | 2.84503151 |
| 141 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.83131801 |
| 142 | T cell receptor signaling pathway (GO:0050852) | 2.83101676 |
| 143 | regulation of RIG-I signaling pathway (GO:0039535) | 2.82217824 |
| 144 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.80961108 |
| 145 | regulation of histone H3-K4 methylation (GO:0051569) | 2.80548760 |
| 146 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.79250061 |
| 147 | response to magnesium ion (GO:0032026) | 2.79022143 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.78327100 |
| 149 | deoxyribose phosphate catabolic process (GO:0046386) | 2.77786822 |
| 150 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.75637419 |
| 151 | deoxyribose phosphate metabolic process (GO:0019692) | 2.75153799 |
| 152 | response to lipoprotein particle (GO:0055094) | 2.74488706 |
| 153 | positive regulation of histone methylation (GO:0031062) | 2.74477756 |
| 154 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.74454739 |
| 155 | negative regulation of protein oligomerization (GO:0032460) | 2.74262061 |
| 156 | T cell homeostasis (GO:0043029) | 2.73096194 |
| 157 | positive regulation of isotype switching (GO:0045830) | 2.72908640 |
| 158 | lymphocyte homeostasis (GO:0002260) | 2.72830489 |
| 159 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.72442739 |
| 160 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.70714993 |
| 161 | positive regulation of Rap GTPase activity (GO:0032854) | 2.70491009 |
| 162 | heart trabecula morphogenesis (GO:0061384) | 2.69852804 |
| 163 | cytochrome complex assembly (GO:0017004) | 2.69516065 |
| 164 | positive regulation of amino acid transport (GO:0051957) | 2.69379044 |
| 165 | positive regulation of protein deacetylation (GO:0090312) | 2.69048768 |
| 166 | monoamine transport (GO:0015844) | 2.68851071 |
| 167 | ubiquinone metabolic process (GO:0006743) | 2.68389595 |
| 168 | seminiferous tubule development (GO:0072520) | 2.68293237 |
| 169 | piRNA metabolic process (GO:0034587) | 2.66503011 |
| 170 | mismatch repair (GO:0006298) | 2.65385521 |
| 171 | rRNA modification (GO:0000154) | 2.64982948 |
| 172 | interkinetic nuclear migration (GO:0022027) | 2.62700753 |
| 173 | hyperosmotic salinity response (GO:0042538) | 2.62461976 |
| 174 | DNA double-strand break processing (GO:0000729) | 2.59321260 |
| 175 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.58074080 |
| 176 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.58074080 |
| 177 | inositol metabolic process (GO:0006020) | 2.57921167 |
| 178 | purine-containing compound salvage (GO:0043101) | 2.57487076 |
| 179 | single strand break repair (GO:0000012) | 2.55911034 |
| 180 | negative regulation of mRNA metabolic process (GO:1903312) | 2.55873424 |
| 181 | regulation of hematopoietic progenitor cell differentiation (GO:1901532) | 2.55288694 |
| 182 | replication fork processing (GO:0031297) | 2.54963124 |
| 183 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.54492587 |
| 184 | GTP biosynthetic process (GO:0006183) | 2.51464497 |
| 185 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.50713344 |
| 186 | postreplication repair (GO:0006301) | 2.49310866 |
| 187 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.49192750 |
| 188 | erythrocyte maturation (GO:0043249) | 2.47923550 |
| 189 | adenosine metabolic process (GO:0046085) | 2.46697581 |
| 190 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.44782234 |
| 191 | autophagic vacuole fusion (GO:0000046) | 2.44291690 |
| 192 | regulation of B cell apoptotic process (GO:0002902) | 2.42548011 |
| 193 | positive regulation of organic acid transport (GO:0032892) | 2.42547046 |
| 194 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.40690889 |
| 195 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.40288742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 5.89588251 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.85825061 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.40008955 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31269472 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 4.09009253 |
| 6 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.85615074 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.63218854 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.56263813 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.53891652 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.51882848 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.31955836 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.21539144 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13645791 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.07381915 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.04741709 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.84276108 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 2.83327190 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.81039576 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.75790098 |
| 20 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.67998652 |
| 21 | * MYB_26560356_Chip-Seq_TH2_Human | 2.67209248 |
| 22 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64230038 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.63642540 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.63623802 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.60823035 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.58469506 |
| 27 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.54173414 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.52634378 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51614808 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.47027892 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39381771 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.34005161 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 2.29670693 |
| 34 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.25696401 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 2.21478596 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.17082225 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.13175541 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.12916863 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11837914 |
| 40 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.06609860 |
| 41 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.02495763 |
| 42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96571405 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93381652 |
| 44 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92651481 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.90277583 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.86639415 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.85261137 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83965903 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83230634 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80743663 |
| 51 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.80243479 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78011210 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77990391 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75347918 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.71206654 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70514930 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.67730566 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.66713423 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.63267753 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.63190529 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62493555 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58315683 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58258520 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58236389 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.56931623 |
| 66 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54271361 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.54201376 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.52375712 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.50983685 |
| 70 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.50926411 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50036015 |
| 72 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.48740653 |
| 73 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.48441440 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47173574 |
| 75 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44919600 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42156205 |
| 77 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41487443 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39796636 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.39702406 |
| 80 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.39147983 |
| 81 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38997164 |
| 82 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.37011047 |
| 83 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36195700 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34136296 |
| 85 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32967691 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32528331 |
| 87 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29843672 |
| 88 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28797178 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28613189 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28225594 |
| 91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28169803 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28069115 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27195279 |
| 94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26752341 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26435482 |
| 96 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22959278 |
| 97 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.22959278 |
| 98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21840961 |
| 99 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.21804428 |
| 100 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20729884 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20237934 |
| 102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.19276881 |
| 103 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18779679 |
| 104 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.18302512 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.18224252 |
| 106 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.15475079 |
| 107 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.15475079 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15126823 |
| 109 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.14578272 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14538653 |
| 111 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12671515 |
| 112 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12544125 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10696858 |
| 114 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.09894896 |
| 115 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09497845 |
| 116 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09377967 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08581732 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05396691 |
| 119 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05072426 |
| 120 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.03480338 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01190826 |
| 122 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00865575 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99255059 |
| 124 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.98930627 |
| 125 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98467462 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97723810 |
| 127 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97323502 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97192868 |
| 129 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96874341 |
| 130 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.95268295 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94769203 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94658760 |
| 133 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92456292 |
| 134 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92400058 |
| 135 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.92192473 |
| 136 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91053116 |
| 137 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.90995497 |
| 138 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89994786 |
| 139 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89527758 |
| 140 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89231542 |
| 141 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.89223960 |
| 142 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.89223960 |
| 143 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.89203354 |
| 144 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88911285 |
| 145 | * NCOR_22424771_ChIP-Seq_293T_Human | 0.88648676 |
| 146 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88410458 |
| 147 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.88027192 |
| 148 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.87150346 |
| 149 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.86987966 |
| 150 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86642704 |
| 151 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85517564 |
| 152 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84786320 |
| 153 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83800435 |
| 154 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.83364192 |
| 155 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83312572 |
| 156 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.82909184 |
| 157 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.82798033 |
| 158 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82381342 |
| 159 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82380588 |
| 160 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80695300 |
| 161 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80309979 |
| 162 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.79962941 |
| 163 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.79962941 |
| 164 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76912753 |
| 165 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.76080331 |
| 166 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.75118864 |
| 167 | * ELF5_23300383_ChIP-Seq_T47D_Human | 0.72218704 |
| 168 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.71531321 |
| 169 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71276584 |
| 170 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70359823 |
| 171 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.69224051 |
| 172 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68539720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.16062773 |
| 2 | MP0004147_increased_porphyrin_level | 3.69635573 |
| 3 | MP0002396_abnormal_hematopoietic_system | 3.67997666 |
| 4 | MP0000685_abnormal_immune_system | 3.67458933 |
| 5 | MP0001800_abnormal_humoral_immune | 3.62619029 |
| 6 | MP0001790_abnormal_immune_system | 3.21676536 |
| 7 | MP0005387_immune_system_phenotype | 3.21676536 |
| 8 | MP0009278_abnormal_bone_marrow | 3.10689988 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.84266859 |
| 10 | MP0005646_abnormal_pituitary_gland | 2.74893623 |
| 11 | MP0008058_abnormal_DNA_repair | 2.72963273 |
| 12 | MP0003724_increased_susceptibility_to | 2.72823466 |
| 13 | MP0004264_abnormal_extraembryonic_tissu | 2.61194697 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.59041200 |
| 15 | MP0002723_abnormal_immune_serum | 2.56358857 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.53622928 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.51124156 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.49363431 |
| 19 | MP0001819_abnormal_immune_cell | 2.47920788 |
| 20 | MP0002398_abnormal_bone_marrow | 2.47191073 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.46762158 |
| 22 | MP0005671_abnormal_response_to | 2.43130169 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.42837534 |
| 24 | MP0008057_abnormal_DNA_replication | 2.40951283 |
| 25 | MP0006276_abnormal_autonomic_nervous | 2.34367671 |
| 26 | MP0002736_abnormal_nociception_after | 2.33090344 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.28465502 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.25007114 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.22922956 |
| 30 | MP0000716_abnormal_immune_system | 2.17414792 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.15160736 |
| 32 | MP0001879_abnormal_lymphatic_vessel | 2.09703177 |
| 33 | MP0003045_fibrosis | 2.07712693 |
| 34 | MP0003303_peritoneal_inflammation | 2.06182935 |
| 35 | MP0005025_abnormal_response_to | 1.95876663 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.95254930 |
| 37 | MP0001851_eye_inflammation | 1.92398046 |
| 38 | MP0002405_respiratory_system_inflammati | 1.88286673 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.86662044 |
| 40 | MP0002419_abnormal_innate_immunity | 1.85462962 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.85312035 |
| 42 | MP0002429_abnormal_blood_cell | 1.83806868 |
| 43 | MP0004947_skin_inflammation | 1.82579991 |
| 44 | MP0002722_abnormal_immune_system | 1.80748472 |
| 45 | MP0008872_abnormal_physiological_respon | 1.80723792 |
| 46 | MP0002006_tumorigenesis | 1.80139751 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.79903735 |
| 48 | MP0001873_stomach_inflammation | 1.78835087 |
| 49 | MP0006054_spinal_hemorrhage | 1.78699151 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 1.77481264 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.75502534 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.68597904 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.65550635 |
| 54 | MP0005075_abnormal_melanosome_morpholog | 1.64550929 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.63094063 |
| 56 | MP0003718_maternal_effect | 1.59685971 |
| 57 | MP0002102_abnormal_ear_morphology | 1.58856215 |
| 58 | MP0002009_preneoplasia | 1.58470531 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.56475632 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.53491189 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.51714541 |
| 62 | MP0008995_early_reproductive_senescence | 1.51005779 |
| 63 | MP0010094_abnormal_chromosome_stability | 1.50956449 |
| 64 | MP0004510_myositis | 1.49733455 |
| 65 | MP0001853_heart_inflammation | 1.49338716 |
| 66 | MP0000015_abnormal_ear_pigmentation | 1.48597591 |
| 67 | MP0005310_abnormal_salivary_gland | 1.46685027 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.46318683 |
| 69 | MP0003436_decreased_susceptibility_to | 1.45101673 |
| 70 | MP0002234_abnormal_pharynx_morphology | 1.44983440 |
| 71 | MP0008004_abnormal_stomach_pH | 1.42261096 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.39846098 |
| 73 | MP0005410_abnormal_fertilization | 1.39579434 |
| 74 | MP0004233_abnormal_muscle_weight | 1.37629588 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 1.37329714 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.36110813 |
| 77 | MP0005670_abnormal_white_adipose | 1.34841231 |
| 78 | MP0002735_abnormal_chemical_nociception | 1.32905006 |
| 79 | MP0006082_CNS_inflammation | 1.30214783 |
| 80 | MP0003787_abnormal_imprinting | 1.30102564 |
| 81 | MP0005551_abnormal_eye_electrophysiolog | 1.28063373 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.27669993 |
| 83 | MP0004145_abnormal_muscle_electrophysio | 1.27499687 |
| 84 | MP0005174_abnormal_tail_pigmentation | 1.25427149 |
| 85 | MP0002733_abnormal_thermal_nociception | 1.24763024 |
| 86 | MP0000858_altered_metastatic_potential | 1.24653040 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 1.22274226 |
| 88 | MP0000516_abnormal_urinary_system | 1.22274226 |
| 89 | MP0009697_abnormal_copulation | 1.21729234 |
| 90 | MP0002132_abnormal_respiratory_system | 1.20698733 |
| 91 | MP0000767_abnormal_smooth_muscle | 1.20589672 |
| 92 | MP0003866_abnormal_defecation | 1.20315878 |
| 93 | MP0001664_abnormal_digestion | 1.20199212 |
| 94 | MP0008789_abnormal_olfactory_epithelium | 1.17379408 |
| 95 | MP0005083_abnormal_biliary_tract | 1.14471646 |
| 96 | MP0009785_altered_susceptibility_to | 1.12971796 |
| 97 | MP0002095_abnormal_skin_pigmentation | 1.11683168 |
| 98 | MP0005220_abnormal_exocrine_pancreas | 1.11176232 |
| 99 | MP0003646_muscle_fatigue | 1.08685203 |
| 100 | MP0003880_abnormal_central_pattern | 1.08494906 |
| 101 | MP0003943_abnormal_hepatobiliary_system | 1.07429660 |
| 102 | MP0002136_abnormal_kidney_physiology | 1.06963034 |
| 103 | MP0001533_abnormal_skeleton_physiology | 1.06693466 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 1.05048328 |
| 105 | MP0000230_abnormal_systemic_arterial | 1.03654430 |
| 106 | MP0006292_abnormal_olfactory_placode | 1.02835048 |
| 107 | MP0000465_gastrointestinal_hemorrhage | 1.02120552 |
| 108 | MP0001986_abnormal_taste_sensitivity | 1.01956815 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 1.01122315 |
| 110 | MP0003786_premature_aging | 1.00439916 |
| 111 | MP0000490_abnormal_crypts_of | 1.00388971 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.99751403 |
| 113 | MP0001661_extended_life_span | 0.99737131 |
| 114 | MP0002160_abnormal_reproductive_system | 0.97408737 |
| 115 | MP0004142_abnormal_muscle_tone | 0.96831388 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.95302763 |
| 117 | MP0003091_abnormal_cell_migration | 0.95166866 |
| 118 | MP0002933_joint_inflammation | 0.95053083 |
| 119 | MP0001958_emphysema | 0.93195242 |
| 120 | MP0002928_abnormal_bile_duct | 0.88946975 |
| 121 | MP0004043_abnormal_pH_regulation | 0.88675316 |
| 122 | MP0001881_abnormal_mammary_gland | 0.86091452 |
| 123 | MP0003186_abnormal_redox_activity | 0.85489364 |
| 124 | MP0005389_reproductive_system_phenotype | 0.84499514 |
| 125 | MP0005266_abnormal_metabolism | 0.82792133 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.82613017 |
| 127 | MP0003656_abnormal_erythrocyte_physiolo | 0.82588724 |
| 128 | MP0005397_hematopoietic_system_phenotyp | 0.82358931 |
| 129 | MP0001545_abnormal_hematopoietic_system | 0.82358931 |
| 130 | MP0008469_abnormal_protein_level | 0.82336478 |
| 131 | MP0001929_abnormal_gametogenesis | 0.81930269 |
| 132 | MP0001764_abnormal_homeostasis | 0.81818322 |
| 133 | MP0003698_abnormal_male_reproductive | 0.81790270 |
| 134 | MP0008873_increased_physiological_sensi | 0.81096260 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.80871819 |
| 136 | MP0001765_abnormal_ion_homeostasis | 0.80303255 |
| 137 | MP0005165_increased_susceptibility_to | 0.79125336 |
| 138 | MP0000569_abnormal_digit_pigmentation | 0.76845096 |
| 139 | MP0003638_abnormal_response/metabolism_ | 0.76257583 |
| 140 | MP0004130_abnormal_muscle_cell | 0.76018822 |
| 141 | MP0006072_abnormal_retinal_apoptosis | 0.75501750 |
| 142 | MP0000249_abnormal_blood_vessel | 0.75017960 |
| 143 | MP0003828_pulmonary_edema | 0.74601570 |
| 144 | MP0002168_other_aberrant_phenotype | 0.73575957 |
| 145 | MP0001970_abnormal_pain_threshold | 0.73212852 |
| 146 | MP0002837_dystrophic_cardiac_calcinosis | 0.72588896 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.71941582 |
| 148 | MP0000631_abnormal_neuroendocrine_gland | 0.71526544 |
| 149 | MP0003453_abnormal_keratinocyte_physiol | 0.70804299 |
| 150 | MP0001529_abnormal_vocalization | 0.70359361 |
| 151 | MP0006035_abnormal_mitochondrial_morpho | 0.69576016 |
| 152 | MP0005164_abnormal_response_to | 0.67091820 |
| 153 | MP0009764_decreased_sensitivity_to | 0.66569749 |
| 154 | MP0005058_abnormal_lysosome_morphology | 0.65683027 |
| 155 | MP0010368_abnormal_lymphatic_system | 0.65639253 |
| 156 | MP0003191_abnormal_cellular_cholesterol | 0.64640376 |
| 157 | MP0005023_abnormal_wound_healing | 0.64369014 |
| 158 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64213305 |
| 159 | MP0002925_abnormal_cardiovascular_devel | 0.64127716 |
| 160 | MP0002019_abnormal_tumor_incidence | 0.63839713 |
| 161 | MP0003448_altered_tumor_morphology | 0.63053316 |
| 162 | MP0002998_abnormal_bone_remodeling | 0.62278012 |
| 163 | MP0008007_abnormal_cellular_replicative | 0.62189441 |
| 164 | MP0000653_abnormal_sex_gland | 0.62078843 |
| 165 | MP0001915_intracranial_hemorrhage | 0.62078373 |
| 166 | MP0005499_abnormal_olfactory_system | 0.61625559 |
| 167 | MP0005394_taste/olfaction_phenotype | 0.61625559 |
| 168 | MP0000343_altered_response_to | 0.61205836 |
| 169 | MP0002086_abnormal_extraembryonic_tissu | 0.59187681 |
| 170 | MP0005535_abnormal_body_temperature | 0.58882985 |
| 171 | MP0001188_hyperpigmentation | 0.58587420 |
| 172 | MP0003111_abnormal_nucleus_morphology | 0.58308128 |
| 173 | MP0000371_diluted_coat_color | 0.56838397 |
| 174 | MP0009115_abnormal_fat_cell | 0.56688183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 5.76751510 |
| 2 | Alveolar cell carcinoma (HP:0006519) | 5.22613361 |
| 3 | Neoplasm of the tracheobronchial system (HP:0100552) | 5.00305687 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.88643175 |
| 5 | Colitis (HP:0002583) | 4.73844346 |
| 6 | Petechiae (HP:0000967) | 4.50362732 |
| 7 | IgM deficiency (HP:0002850) | 4.16534439 |
| 8 | Nasal polyposis (HP:0100582) | 4.07675892 |
| 9 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 4.03864291 |
| 10 | Toxemia of pregnancy (HP:0100603) | 4.01173558 |
| 11 | Abnormality of the nasal mucosa (HP:0000433) | 3.87892620 |
| 12 | Disinhibition (HP:0000734) | 3.80884833 |
| 13 | Recurrent viral infections (HP:0004429) | 3.79121003 |
| 14 | Volvulus (HP:0002580) | 3.68597088 |
| 15 | Easy fatigability (HP:0003388) | 3.66734356 |
| 16 | Mutism (HP:0002300) | 3.63106370 |
| 17 | Inflammation of the large intestine (HP:0002037) | 3.60179054 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 3.57515867 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.48452779 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.46066292 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 3.37173058 |
| 22 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.36837350 |
| 23 | Pustule (HP:0200039) | 3.35630243 |
| 24 | Cellulitis (HP:0100658) | 3.31858480 |
| 25 | Tubulointerstitial nephritis (HP:0001970) | 3.31824754 |
| 26 | Metaphyseal dysplasia (HP:0100255) | 3.26203383 |
| 27 | Stomatitis (HP:0010280) | 3.25115536 |
| 28 | Increased mean platelet volume (HP:0011877) | 3.21116186 |
| 29 | Abnormality of lateral ventricle (HP:0030047) | 3.19574723 |
| 30 | Epistaxis (HP:0000421) | 3.18246304 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.16540322 |
| 32 | Renal cortical cysts (HP:0000803) | 3.16182434 |
| 33 | Constricted visual fields (HP:0001133) | 3.13439407 |
| 34 | Abnormal platelet volume (HP:0011876) | 3.08426076 |
| 35 | Chronic otitis media (HP:0000389) | 3.07640674 |
| 36 | Gastrointestinal stroma tumor (HP:0100723) | 3.03844242 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 3.03740777 |
| 38 | Papilloma (HP:0012740) | 3.01582187 |
| 39 | Verrucae (HP:0200043) | 3.01582187 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99268160 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99268160 |
| 42 | Acute lymphatic leukemia (HP:0006721) | 2.98497453 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.98392397 |
| 44 | Menorrhagia (HP:0000132) | 2.98297400 |
| 45 | Fatigable weakness (HP:0003473) | 2.97128051 |
| 46 | Abnormality of the neuromuscular junction (HP:0003398) | 2.97128051 |
| 47 | Dyschromatopsia (HP:0007641) | 2.95931432 |
| 48 | Recurrent abscess formation (HP:0002722) | 2.94683492 |
| 49 | Abnormality of the prostate (HP:0008775) | 2.90120203 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.89550109 |
| 51 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.88671021 |
| 52 | Eczematoid dermatitis (HP:0000976) | 2.84571699 |
| 53 | Congenital stationary night blindness (HP:0007642) | 2.82934817 |
| 54 | Pancreatic cysts (HP:0001737) | 2.82496657 |
| 55 | Viral hepatitis (HP:0006562) | 2.82223151 |
| 56 | Large earlobe (HP:0009748) | 2.81407941 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.80560083 |
| 58 | Pancreatic fibrosis (HP:0100732) | 2.80168076 |
| 59 | Recurrent bacterial skin infections (HP:0005406) | 2.79156529 |
| 60 | Decreased muscle mass (HP:0003199) | 2.76532955 |
| 61 | Interstitial pulmonary disease (HP:0006530) | 2.75570904 |
| 62 | Attenuation of retinal blood vessels (HP:0007843) | 2.74378933 |
| 63 | Myositis (HP:0100614) | 2.71758148 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66954133 |
| 65 | Persistence of primary teeth (HP:0006335) | 2.59066162 |
| 66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.58795900 |
| 67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.58579143 |
| 68 | Chronic diarrhea (HP:0002028) | 2.55988852 |
| 69 | IgA deficiency (HP:0002720) | 2.53915778 |
| 70 | Aplastic anemia (HP:0001915) | 2.47375004 |
| 71 | Recurrent skin infections (HP:0001581) | 2.46057841 |
| 72 | Type 2 muscle fiber atrophy (HP:0003554) | 2.44501340 |
| 73 | Severe visual impairment (HP:0001141) | 2.41683190 |
| 74 | Hepatocellular necrosis (HP:0001404) | 2.40601797 |
| 75 | Porencephaly (HP:0002132) | 2.40327986 |
| 76 | Bile duct proliferation (HP:0001408) | 2.38396225 |
| 77 | Abnormal biliary tract physiology (HP:0012439) | 2.38396225 |
| 78 | Purpura (HP:0000979) | 2.33899764 |
| 79 | Poikilocytosis (HP:0004447) | 2.33458343 |
| 80 | Stomach cancer (HP:0012126) | 2.31427316 |
| 81 | Hepatic necrosis (HP:0002605) | 2.29999401 |
| 82 | Gingival bleeding (HP:0000225) | 2.29194006 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28263175 |
| 84 | Inappropriate behavior (HP:0000719) | 2.28054073 |
| 85 | IgG deficiency (HP:0004315) | 2.27785882 |
| 86 | Muscle fiber atrophy (HP:0100295) | 2.27246322 |
| 87 | Prostate neoplasm (HP:0100787) | 2.26734752 |
| 88 | Thyroid-stimulating hormone excess (HP:0002925) | 2.26248779 |
| 89 | Mitochondrial inheritance (HP:0001427) | 2.25345439 |
| 90 | True hermaphroditism (HP:0010459) | 2.25288908 |
| 91 | B lymphocytopenia (HP:0010976) | 2.25153835 |
| 92 | Abnormality of B cell number (HP:0010975) | 2.25153835 |
| 93 | Striae distensae (HP:0001065) | 2.24352586 |
| 94 | Nephronophthisis (HP:0000090) | 2.23961127 |
| 95 | Arterial tortuosity (HP:0005116) | 2.23322572 |
| 96 | Neoplasm of the lung (HP:0100526) | 2.22481884 |
| 97 | Lymphopenia (HP:0001888) | 2.22464768 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21134382 |
| 99 | Abnormality of midbrain morphology (HP:0002418) | 2.20685868 |
| 100 | Molar tooth sign on MRI (HP:0002419) | 2.20685868 |
| 101 | Meningitis (HP:0001287) | 2.20661147 |
| 102 | Nonprogressive disorder (HP:0003680) | 2.20148747 |
| 103 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.19563330 |
| 104 | Decreased central vision (HP:0007663) | 2.18534571 |
| 105 | Failure to thrive in infancy (HP:0001531) | 2.16464302 |
| 106 | Impaired platelet aggregation (HP:0003540) | 2.15303968 |
| 107 | Abnormal platelet function (HP:0011869) | 2.15303968 |
| 108 | Abnormality of T cells (HP:0002843) | 2.14188274 |
| 109 | Abnormality of the renal medulla (HP:0100957) | 2.14144550 |
| 110 | Cutis marmorata (HP:0000965) | 2.13716076 |
| 111 | Increased CSF lactate (HP:0002490) | 2.13073445 |
| 112 | Paralysis (HP:0003470) | 2.11501653 |
| 113 | Vascular tortuosity (HP:0004948) | 2.11070188 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.10331089 |
| 115 | Myelodysplasia (HP:0002863) | 2.10220613 |
| 116 | Emphysema (HP:0002097) | 2.09129749 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08370615 |
| 118 | Increased cerebral lipofuscin (HP:0011813) | 2.08106441 |
| 119 | Medial flaring of the eyebrow (HP:0010747) | 2.06337307 |
| 120 | Subacute progressive viral hepatitis (HP:0006572) | 2.06210006 |
| 121 | Mediastinal lymphadenopathy (HP:0100721) | 2.06182540 |
| 122 | Agitation (HP:0000713) | 2.05775770 |
| 123 | Cerebral aneurysm (HP:0004944) | 2.05628693 |
| 124 | Abnormality of T cell physiology (HP:0011840) | 2.05535040 |
| 125 | Weak cry (HP:0001612) | 2.05457410 |
| 126 | Central scotoma (HP:0000603) | 2.04995290 |
| 127 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.04938812 |
| 128 | Neoplasm of the respiratory system (HP:0100606) | 2.04745864 |
| 129 | Blepharitis (HP:0000498) | 2.03719905 |
| 130 | Spondylolisthesis (HP:0003302) | 2.02849062 |
| 131 | Acute myeloid leukemia (HP:0004808) | 2.02236651 |
| 132 | Gaze-evoked nystagmus (HP:0000640) | 2.02074417 |
| 133 | Hepatitis (HP:0012115) | 2.01332719 |
| 134 | Tapered finger (HP:0001182) | 2.00506962 |
| 135 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00200079 |
| 136 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00200079 |
| 137 | Abnormal protein glycosylation (HP:0012346) | 2.00200079 |
| 138 | Abnormal glycosylation (HP:0012345) | 2.00200079 |
| 139 | Exercise-induced myalgia (HP:0003738) | 1.99915761 |
| 140 | Aortic aneurysm (HP:0004942) | 1.98756164 |
| 141 | Abnormality of T cell number (HP:0011839) | 1.98476817 |
| 142 | Abnormality of male internal genitalia (HP:0000022) | 1.96934370 |
| 143 | Bronchitis (HP:0012387) | 1.96644923 |
| 144 | Vasculitis (HP:0002633) | 1.94937839 |
| 145 | Apathy (HP:0000741) | 1.94521111 |
| 146 | Acute encephalopathy (HP:0006846) | 1.94007364 |
| 147 | T lymphocytopenia (HP:0005403) | 1.93088805 |
| 148 | Polyphagia (HP:0002591) | 1.92629134 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.92462971 |
| 150 | Osteomyelitis (HP:0002754) | 1.92068536 |
| 151 | Abnormality of the intervertebral disk (HP:0005108) | 1.91654081 |
| 152 | Esophageal varix (HP:0002040) | 1.90900577 |
| 153 | Prominent nose (HP:0000448) | 1.90833530 |
| 154 | Increased serum lactate (HP:0002151) | 1.90147703 |
| 155 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.88848066 |
| 156 | Hematochezia (HP:0002573) | 1.88637653 |
| 157 | Acute necrotizing encephalopathy (HP:0006965) | 1.87755620 |
| 158 | Amyotrophic lateral sclerosis (HP:0007354) | 1.87666581 |
| 159 | Hypoplasia of the iris (HP:0007676) | 1.87458784 |
| 160 | Leukocytosis (HP:0001974) | 1.83890661 |
| 161 | Widely spaced teeth (HP:0000687) | 1.82818169 |
| 162 | Recurrent pneumonia (HP:0006532) | 1.81748931 |
| 163 | Abnormality of iron homeostasis (HP:0011031) | 1.81434846 |
| 164 | Tubulointerstitial abnormality (HP:0001969) | 1.80489880 |
| 165 | Congenital hepatic fibrosis (HP:0002612) | 1.79494290 |
| 166 | Hypoplasia of the fovea (HP:0007750) | 1.79158336 |
| 167 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.79158336 |
| 168 | Bicuspid aortic valve (HP:0001647) | 1.77165474 |
| 169 | Abnormal pupillary function (HP:0007686) | 1.77058243 |
| 170 | Reticulocytosis (HP:0001923) | 1.76918174 |
| 171 | Clubbing of toes (HP:0100760) | 1.76470831 |
| 172 | Cerebral palsy (HP:0100021) | 1.75905360 |
| 173 | Neoplasm of the adrenal cortex (HP:0100641) | 1.75687430 |
| 174 | Diminished motivation (HP:0000745) | 1.75539008 |
| 175 | Progressive macrocephaly (HP:0004481) | 1.75482641 |
| 176 | Progressive microcephaly (HP:0000253) | 1.74717754 |
| 177 | Optic disc pallor (HP:0000543) | 1.74670558 |
| 178 | Polydipsia (HP:0001959) | 1.73043976 |
| 179 | Abnormal drinking behavior (HP:0030082) | 1.73043976 |
| 180 | Colon cancer (HP:0003003) | 1.72623057 |
| 181 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.72532489 |
| 182 | Abnormality of alanine metabolism (HP:0010916) | 1.72532489 |
| 183 | Hyperalaninemia (HP:0003348) | 1.72532489 |
| 184 | Cystic liver disease (HP:0006706) | 1.71180224 |
| 185 | Thrombocytosis (HP:0001894) | 1.69113164 |
| 186 | Albinism (HP:0001022) | 1.66599457 |
| 187 | Dysautonomia (HP:0002459) | 1.66583118 |
| 188 | Type I transferrin isoform profile (HP:0003642) | 1.65431033 |
| 189 | Amelogenesis imperfecta (HP:0000705) | 1.65066312 |
| 190 | Tinnitus (HP:0000360) | 1.64227272 |
| 191 | Hyperthyroidism (HP:0000836) | 1.63093224 |
| 192 | Ketosis (HP:0001946) | 1.62299051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BMPR2 | 7.22514907 |
| 2 | DMPK | 3.86323302 |
| 3 | MAP4K1 | 3.71788664 |
| 4 | BCKDK | 3.02213377 |
| 5 | FRK | 3.00982309 |
| 6 | SCYL2 | 2.81304416 |
| 7 | ITK | 2.66924334 |
| 8 | STK10 | 2.63331765 |
| 9 | TGFBR2 | 2.42896637 |
| 10 | IKBKB | 2.35025741 |
| 11 | JAK3 | 2.25636965 |
| 12 | TYK2 | 2.15101170 |
| 13 | ZAK | 2.07452383 |
| 14 | ADRBK2 | 2.03688167 |
| 15 | MAPK15 | 1.91004956 |
| 16 | MAP4K2 | 1.82217599 |
| 17 | MAP3K14 | 1.80783738 |
| 18 | MAP3K13 | 1.79768078 |
| 19 | FGFR4 | 1.79656238 |
| 20 | EIF2AK3 | 1.68878347 |
| 21 | ZAP70 | 1.68810105 |
| 22 | IKBKE | 1.65419878 |
| 23 | FGFR3 | 1.64694222 |
| 24 | MAPK13 | 1.63026747 |
| 25 | VRK2 | 1.59965653 |
| 26 | EIF2AK1 | 1.59441446 |
| 27 | CCNB1 | 1.57101775 |
| 28 | GRK6 | 1.55410123 |
| 29 | TBK1 | 1.54528072 |
| 30 | GSK3A | 1.53660799 |
| 31 | WNK3 | 1.51193198 |
| 32 | TAOK1 | 1.49406216 |
| 33 | CDC7 | 1.48554475 |
| 34 | TNK2 | 1.44699563 |
| 35 | CDK8 | 1.43908462 |
| 36 | JAK1 | 1.43833287 |
| 37 | TXK | 1.41509660 |
| 38 | LRRK2 | 1.40752972 |
| 39 | VRK1 | 1.38223423 |
| 40 | CDK9 | 1.32964794 |
| 41 | EPHB1 | 1.32811878 |
| 42 | KDR | 1.31723182 |
| 43 | MAP3K11 | 1.30973270 |
| 44 | MARK2 | 1.29369284 |
| 45 | PINK1 | 1.27278803 |
| 46 | CHUK | 1.22923850 |
| 47 | TIE1 | 1.22665609 |
| 48 | DAPK2 | 1.21337640 |
| 49 | NUAK1 | 1.20643887 |
| 50 | BLK | 1.19780873 |
| 51 | EPHA3 | 1.12367932 |
| 52 | MAP3K5 | 1.11470175 |
| 53 | PTK6 | 1.11429633 |
| 54 | MAPKAPK3 | 1.11380322 |
| 55 | TEC | 1.11051547 |
| 56 | NLK | 1.10686431 |
| 57 | SYK | 1.09644806 |
| 58 | CSK | 1.07036283 |
| 59 | MUSK | 1.07000296 |
| 60 | TSSK6 | 1.06479441 |
| 61 | CSNK1G3 | 1.05871222 |
| 62 | IRAK4 | 1.05137989 |
| 63 | IRAK1 | 1.04099307 |
| 64 | PIM2 | 1.02380120 |
| 65 | TRIB3 | 1.02169106 |
| 66 | MAP3K7 | 1.01058737 |
| 67 | INSRR | 0.98771282 |
| 68 | KIT | 0.98695156 |
| 69 | HIPK2 | 0.97553197 |
| 70 | BMPR1B | 0.97022999 |
| 71 | CSF1R | 0.95707794 |
| 72 | MAPKAPK5 | 0.95228027 |
| 73 | CSNK1G2 | 0.92019594 |
| 74 | MAP3K4 | 0.90736355 |
| 75 | ERN1 | 0.90293014 |
| 76 | HCK | 0.90142659 |
| 77 | PAK4 | 0.89623065 |
| 78 | PRKCQ | 0.89438479 |
| 79 | ALK | 0.87808180 |
| 80 | FLT3 | 0.87793121 |
| 81 | GRK1 | 0.86741465 |
| 82 | RIPK4 | 0.85924587 |
| 83 | LCK | 0.84264259 |
| 84 | PRKCH | 0.83585096 |
| 85 | RPS6KB2 | 0.83527454 |
| 86 | RIPK1 | 0.83522259 |
| 87 | PIK3CA | 0.83511211 |
| 88 | RPS6KA5 | 0.83160702 |
| 89 | BTK | 0.82365302 |
| 90 | RPS6KA4 | 0.80707633 |
| 91 | NME2 | 0.79444037 |
| 92 | TRPM7 | 0.78346693 |
| 93 | CHEK2 | 0.78078399 |
| 94 | CSNK1G1 | 0.77945425 |
| 95 | SGK3 | 0.77350737 |
| 96 | EEF2K | 0.76116730 |
| 97 | DAPK1 | 0.74895586 |
| 98 | MARK3 | 0.73867551 |
| 99 | PIK3CG | 0.73171655 |
| 100 | ATR | 0.73030322 |
| 101 | PRKD2 | 0.71229694 |
| 102 | MAP2K3 | 0.70755539 |
| 103 | LATS2 | 0.70344807 |
| 104 | CSNK1A1L | 0.68401349 |
| 105 | CDK6 | 0.66527877 |
| 106 | PIM1 | 0.62380819 |
| 107 | CLK1 | 0.62320845 |
| 108 | PDGFRB | 0.62070175 |
| 109 | ADRBK1 | 0.61628934 |
| 110 | TAOK3 | 0.60499428 |
| 111 | CAMK1G | 0.60423085 |
| 112 | MAP2K7 | 0.60308341 |
| 113 | FES | 0.59570385 |
| 114 | SIK2 | 0.57366097 |
| 115 | MKNK1 | 0.56856291 |
| 116 | PRKD1 | 0.56182961 |
| 117 | PLK2 | 0.56088379 |
| 118 | MELK | 0.54852683 |
| 119 | PLK4 | 0.53851218 |
| 120 | EPHB2 | 0.52466086 |
| 121 | JAK2 | 0.52454121 |
| 122 | CDK12 | 0.49511761 |
| 123 | ABL2 | 0.49238121 |
| 124 | WNK1 | 0.48455592 |
| 125 | TGFBR1 | 0.48124227 |
| 126 | RAF1 | 0.47798827 |
| 127 | PTK2B | 0.47251543 |
| 128 | RET | 0.46820367 |
| 129 | PDK1 | 0.46402250 |
| 130 | STK24 | 0.46086352 |
| 131 | MATK | 0.44730349 |
| 132 | GRK5 | 0.43190482 |
| 133 | MAPK3 | 0.42912725 |
| 134 | ILK | 0.42280622 |
| 135 | DYRK2 | 0.41748212 |
| 136 | ATM | 0.41693809 |
| 137 | SRPK1 | 0.41534385 |
| 138 | PRKAA1 | 0.41322442 |
| 139 | ERBB3 | 0.41104469 |
| 140 | CDK3 | 0.40956998 |
| 141 | RPS6KA6 | 0.40526867 |
| 142 | MAPK7 | 0.39922696 |
| 143 | GRK7 | 0.39785091 |
| 144 | PKN1 | 0.39377602 |
| 145 | MAP3K9 | 0.38621225 |
| 146 | ABL1 | 0.38348680 |
| 147 | MTOR | 0.38258368 |
| 148 | PRKCE | 0.37494740 |
| 149 | MAPK12 | 0.36713219 |
| 150 | PRKG2 | 0.35562453 |
| 151 | EGFR | 0.35336205 |
| 152 | OXSR1 | 0.34862005 |
| 153 | IRAK2 | 0.34669094 |
| 154 | STK4 | 0.34183685 |
| 155 | LYN | 0.33675537 |
| 156 | MAPK11 | 0.33088726 |
| 157 | DYRK1A | 0.32665214 |
| 158 | MST4 | 0.32291227 |
| 159 | CSNK2A1 | 0.31817648 |
| 160 | PRKAA2 | 0.31618407 |
| 161 | CDK4 | 0.31362640 |
| 162 | DYRK3 | 0.30777340 |
| 163 | IGF1R | 0.30500041 |
| 164 | STK3 | 0.30304521 |
| 165 | BRSK2 | 0.30233610 |
| 166 | MAPK9 | 0.29723739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 3.47514380 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 3.26455232 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.15401711 |
| 4 | Homologous recombination_Homo sapiens_hsa03440 | 3.14870265 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.09818422 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.81251992 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.78773871 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.64941538 |
| 9 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.60881066 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44773054 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.35649388 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26421131 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.21711326 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.16076369 |
| 15 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.14204713 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06704293 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02450351 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.96014510 |
| 19 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.90671377 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.89357963 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85494501 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85460233 |
| 23 | Olfactory transduction_Homo sapiens_hsa04740 | 1.83322619 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76936794 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76852778 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75439383 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72012150 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.71090082 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.69540204 |
| 30 | Phototransduction_Homo sapiens_hsa04744 | 1.69409034 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.68923163 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68612020 |
| 33 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.67649823 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.66414087 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.65971240 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.57012502 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.56781206 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.54846439 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.54107823 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.53266296 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.51213860 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.51030656 |
| 43 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46214738 |
| 44 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.45135709 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41838889 |
| 46 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.40965420 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.39063493 |
| 48 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38777216 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36976981 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36403555 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.36176690 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35561769 |
| 53 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33460002 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 1.32786840 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 1.32656150 |
| 56 | Spliceosome_Homo sapiens_hsa03040 | 1.27592683 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26665581 |
| 58 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25674735 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.25645004 |
| 60 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23222064 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 1.22529298 |
| 62 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16249059 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.14271535 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14157961 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13957475 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12001166 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 1.11371706 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11306501 |
| 69 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10917003 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.10415702 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 1.10078798 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.07982137 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05442317 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05439501 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03376442 |
| 76 | Taste transduction_Homo sapiens_hsa04742 | 1.03231251 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03007322 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02654440 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 1.02091262 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00421569 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99138673 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98378828 |
| 83 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97521391 |
| 84 | Allograft rejection_Homo sapiens_hsa05330 | 0.96576977 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.96071284 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95278103 |
| 87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94748900 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.94698737 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94087863 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.93580846 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.91660190 |
| 92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.91286483 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.90311595 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90173386 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.88422909 |
| 96 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88269504 |
| 97 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87795049 |
| 98 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87297545 |
| 99 | Tuberculosis_Homo sapiens_hsa05152 | 0.86532336 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.86363173 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.84526164 |
| 102 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84071560 |
| 103 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83308125 |
| 104 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80790965 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77802678 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76392266 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.75732187 |
| 108 | Focal adhesion_Homo sapiens_hsa04510 | 0.75723054 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.75174099 |
| 110 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73271766 |
| 111 | RNA transport_Homo sapiens_hsa03013 | 0.72822606 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71967533 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71125812 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70661609 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70598989 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.70329252 |
| 117 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70210188 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69440431 |
| 119 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69213715 |
| 120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67701905 |
| 121 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67401929 |
| 122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67086329 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66755113 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66638023 |
| 125 | Legionellosis_Homo sapiens_hsa05134 | 0.65703461 |
| 126 | Adherens junction_Homo sapiens_hsa04520 | 0.64674634 |
| 127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.64439267 |
| 128 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62805313 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62071968 |
| 130 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60904166 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60559889 |
| 132 | Salivary secretion_Homo sapiens_hsa04970 | 0.59914347 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59122937 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59022593 |
| 135 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58922785 |
| 136 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.58430080 |
| 137 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58294271 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.56407152 |
| 139 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.54707519 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53709001 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53675219 |
| 142 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53481232 |
| 143 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53358884 |
| 144 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53119690 |
| 145 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53039392 |
| 146 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52296358 |
| 147 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.51826231 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.51612582 |
| 149 | Renin secretion_Homo sapiens_hsa04924 | 0.50951387 |
| 150 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50549320 |
| 151 | Lysine degradation_Homo sapiens_hsa00310 | 0.48841257 |
| 152 | Protein export_Homo sapiens_hsa03060 | 0.47450330 |
| 153 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47080403 |
| 154 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46540439 |
| 155 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45595818 |
| 156 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45086309 |
| 157 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45020102 |
| 158 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44644856 |
| 159 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43315315 |
| 160 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.42851117 |
| 161 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42559170 |
| 162 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42508420 |
| 163 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41016002 |
| 164 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.40973173 |
| 165 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40813324 |
| 166 | Long-term depression_Homo sapiens_hsa04730 | 0.40474059 |
| 167 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38429474 |
| 168 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36054089 |
| 169 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.34632023 |
| 170 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34013564 |
| 171 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33547264 |
| 172 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33426768 |
| 173 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32814230 |
| 174 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32521600 |
| 175 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32078866 |
| 176 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30857127 |
| 177 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30503616 |
| 178 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28306508 |

